These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 28952700)

  • 1. [The role of fosfomycin in the management of urinary tract infections].
    Zaitsev AV; Kolontarev KB
    Urologiia; 2017 Sep; (4):91-96. PubMed ID: 28952700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An update on the management of urinary tract infections in the era of antimicrobial resistance.
    Bader MS; Loeb M; Brooks AA
    Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fosfomycin for treatment of uncomplicated lower urinary tract infection].
    Al-Shukri SH; Slesarevskaya MN; Kuzmin IV
    Urologiia; 2018 Dec; (5):153-158. PubMed ID: 30575367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of Fosfomycin against Extended-Spectrum-β-Lactamase-Producing Uropathogens in Patients in the Community and Hospitalized Patients.
    Linsenmeyer K; Strymish J; Weir S; Berg G; Brecher S; Gupta K
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1134-6. PubMed ID: 26596940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral and intravenous fosfomycin in complicated urinary tract infections.
    López-Montesinos I; Horcajada JP
    Rev Esp Quimioter; 2019 May; 32 Suppl 1(Suppl 1):37-44. PubMed ID: 31131591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fosfomycin: past, present and future].
    Baylan O
    Mikrobiyol Bul; 2010 Apr; 44(2):311-21. PubMed ID: 20549968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experience of using the antibacterial drug Fosfomycin Esparma for the treatment of acute uncomplicated cystitis in women].
    Aboyan IA; Orlov YN; Voloshina OA; Orlov NV; Pavlov DS
    Urologiia; 2019 Sep; (4):20-25. PubMed ID: 31535800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of fosfomycin in the treatment of community-acquired lower urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
    Wilson DT; May DB
    Am J Ther; 2013; 20(6):685-90. PubMed ID: 21768870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of recurrent complicated urinary tract infections in children with vesicoureteral reflux.
    Wu TH; Huang FL; Fu LS; Chou CM; Chien YL; Huang CM; Lin CF; Chen PY
    J Microbiol Immunol Infect; 2016 Oct; 49(5):717-722. PubMed ID: 25442872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    Rodríguez-Baño J; Alcalá JC; Cisneros JM; Grill F; Oliver A; Horcajada JP; Tórtola T; Mirelis B; Navarro G; Cuenca M; Esteve M; Peña C; Llanos AC; Cantón R; Pascual A
    Arch Intern Med; 2008 Sep; 168(17):1897-902. PubMed ID: 18809817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic Resistance Patterns Among Uropathogens in Female Outpatients Affected by Uncomplicated Cystitis: Focus on Fosfomycin Trometamol.
    Cai T; Verze P; Arcaniolo D; Pandolfo SD; Smarrazzo F; Manfredi C; Tascini C; Caciagli P; Lanzafame M; De Sio M; Wagenlehner F; Johansen TEB; Palmieri A
    Int J Antimicrob Agents; 2023 Nov; 62(5):106974. PubMed ID: 37739241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of uncomplicated lower urinary tract infections].
    Horcajada JP; García-Palomo D; Fariñas MC
    Enferm Infecc Microbiol Clin; 2005 Dec; 23 Suppl 4():22-7. PubMed ID: 16854355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of fosfomycin alone or combined with cefoxitin in vitro and in vivo in a murine model of urinary tract infection due to Escherichia coli harbouring CTX-M-15-type extended-spectrum β-lactamase.
    Lefort A; Chau F; Lepeule R; Dubée V; Kitzis MD; Dion S; Fantin B
    Int J Antimicrob Agents; 2014 Apr; 43(4):366-9. PubMed ID: 24388117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of combined antibacterial-prebiotic therapy in combination with D-mannose in women with uncomplicated lower urinary tract infection].
    Kuzmenko AV; Kuzmenko VV; Gyaurgiev TA
    Urologiia; 2019 Dec; (6):38-43. PubMed ID: 32003165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Uncomplicated urinary tract infections, what about fosfomycin and nitrofurantoin in 2006?].
    Honderlick P; Cahen P; Gravisse J; Vignon D
    Pathol Biol (Paris); 2006; 54(8-9):462-6. PubMed ID: 17027182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficiency of fosfomycin trometamol for treatment of acute uncomplicated cystitis].
    Kuzmenko AV; Kuzmenko VV; Gyaurgiev TA
    Urologiia; 2018 Dec; (6):70-75. PubMed ID: 30742381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of MDR urinary tract infections with oral fosfomycin: a retrospective analysis.
    Seroy JT; Grim SA; Reid GE; Wellington T; Clark NM
    J Antimicrob Chemother; 2016 Sep; 71(9):2563-8. PubMed ID: 27246234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fosfomycin: use beyond urinary tract and gastrointestinal infections.
    Falagas ME; Giannopoulou KP; Kokolakis GN; Rafailidis PI
    Clin Infect Dis; 2008 Apr; 46(7):1069-77. PubMed ID: 18444827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of fosfomycin tromethamine against extended spectrum beta-lactamase producing urinary tract bacteria.
    Khan IU; Mirza IA; Ikram A; Ali S; Hussain A; Ghafoor T
    J Coll Physicians Surg Pak; 2014 Dec; 24(12):914-7. PubMed ID: 25523727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daily fosfomycin versus levofloxacin for complicated urinary tract infections.
    Rouphael N; Winokur P; Keefer MC; Traenkner J; Drobeniuc A; Doi Y; Munsiff S; Fowler VG; Evans S; Oler RE; Tuyishimire B; Lee M; Ghazaryan V; Chambers HF;
    mBio; 2023 Oct; 14(5):e0167723. PubMed ID: 37698412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.